CoronaryAtlas logo
CoronaryAtlas
ASCVD Risk Atlas
← Back to table
B

Left ventricular hypertrophy

Imaging & Subclinical DiseaseImaging markerriskpartially modifiable
33
evidence score

Also known as: cardiac hypertrophy, hypertrophy, left ventricle hypertrophy, left ventricular mass, lvh

PREVENT status

Not a PREVENT input variable.

Causal support

trial evidence

Score components
lit volume: 16.3meta-analyses: 9.1trials: 7.8genetic: 0MR bonus:

References (42)

2 meta-analyses / systematic reviews

Clinical trials (5)

NCTTitleStatusTypeInterventions
NCT03089333Effects of Dapagliflozin, an SGLT2 Inhibitor, on Hemodynamic Parameters, Target Organ Damage and Obesity Profile in Resistant Hypertensive SubjectsCOMPLETEDINTERVENTIONALDapagliflozin 10mg, Glibenclamide 5Mg Tablet
NCT00738972Left Ventricular Hypertrophy Reduction With Statins in Hypertensives Patients.TERMINATEDINTERVENTIONALvalsartan, pravastatin, simvastatin
NCT05373732Stress Reduction in the Prevention of Left Ventricular Hypertrophy: A Randomized Controlled Trial of Transcendental Meditation and Health Education in Hypertensive African AmericansCOMPLETEDINTERVENTIONALmeditation, Health education control
NCT05942729Etiological DiagnOsis of caRdiac Diseases Based on echoCardiograpHIc Images and Clinical Data.RECRUITINGOBSERVATIONALDetermine the etiology of hypokinetic and hypertrophic heart disease on transthoracic echocardiography data alone
NCT01305304Magnetic Resonance Technique in the Assessment of Exercise-induced Long- and Short-Term Changes in Cardiac Function and MorphologyCOMPLETEDOBSERVATIONALrepeated long term endurance exercise, Other

Genetic associations (0)

None linked.